AAR CORP·4

Jul 25, 2:51 PM ET

Garascia Jessica A. 4

4 · AAR CORP · Filed Jul 25, 2025

Insider Transaction Report

Form 4
Period: 2025-07-23
Garascia Jessica A.
Senior VP, GC, CAO & Secretary
Transactions
  • Award

    Common Stock

    [F1]
    2025-07-23+2,11532,772 total
  • Award

    Common Stock

    [F2]
    2025-07-23+6,34539,117 total
  • Exercise/Conversion

    Common Stock

    2025-07-23$37.74/sh+1,559$58,83740,676 total
  • Sale

    Common Stock

    [F3]
    2025-07-23$77.08/sh1,559$120,16539,117 total
  • Exercise/Conversion

    Common Stock

    2025-07-23$41.88/sh+1,183$49,54440,300 total
  • Sale

    Common Stock

    [F3]
    2025-07-23$77.08/sh1,183$91,18339,117 total
  • Exercise/Conversion

    Common Stock

    2025-07-23$58.27/sh+889$51,80240,006 total
  • Sale

    Common Stock

    [F3]
    2025-07-23$77.08/sh889$68,52239,117 total
  • Award

    Stock Option

    [F4]
    2025-07-23+5,8505,850 total
    Exercise: $79.45From: 2026-07-31Exp: 2035-07-23Common Stock (5,850 underlying)
  • Exercise/Conversion

    Stock Option

    [F5]
    2025-07-231,5590 total
    Exercise: $37.74From: 2022-07-31Exp: 2031-07-12Common Stock (1,559 underlying)
  • Exercise/Conversion

    Stock Option

    [F6]
    2025-07-231,1831,579 total
    Exercise: $41.88From: 2023-07-31Exp: 2032-07-18Common Stock (1,183 underlying)
  • Exercise/Conversion

    Stock Option

    [F7]
    2025-07-238892,965 total
    Exercise: $58.27From: 2024-07-31Exp: 2033-07-24Common Stock (889 underlying)
Footnotes (7)
  • [F1]Award of stock pursuant to Restricted Stock Agreement in transaction exempt under Rule 16b-3.
  • [F2]Award of stock pursuant to a Performance Restricted Stock Agreement in a transaction exempt under Rule 16b-3.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.43 to $79.16 inclusive. The reporting person undertakes to provide AAR CORP. any security holder of AAR CORP. or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2026 and shall vest as follows: 33 and 1/3% on each of July 31, 2026, July 31, 2027 and July 31, 2028.
  • [F5]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2022 and vested as follows: 33 and 1/3% on each of July 31, 2022, July 31, 2023, and July 31, 2024.
  • [F6]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2023 and shall vest as follows: 33 and 1/3% on each of July 31, 2023, July 31, 2024, and July 31, 2025.
  • [F7]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2024 and shall vest as follows: 33 and 1/3% on each of July 31, 2024, July 31, 2025, and July 31, 2026.
Signature
/s/ Katherine Kwiat, power of attorney|2025-07-25

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY: POA